Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited is a globally recognized pharmaceutical manufacturing company specializing in Active Pharmaceutical Ingredients (APIs), high-potency compounds, custom development, and contract manufacturing services. The company was formed through the integration of India’s Dishman Pharmaceuticals and Switzerland-based Carbogen Amcis, creating a strong international organization serving innovative pharmaceutical and biotechnology companies across the world. Headquartered in Ahmedabad, Gujarat, India, with major operations in Switzerland, France, the Netherlands, China, and the United Kingdom, the company provides integrated solutions from process development to commercial manufacturing.

The company’s expertise includes custom API synthesis, highly potent active pharmaceutical ingredients (HPAPIs), antibody-drug conjugate (ADC) payloads, pharmaceutical intermediates, process optimization, and analytical development. Dishman Carbogen Amcis supports customers throughout the entire drug development lifecycle, offering scalable manufacturing backed by advanced process chemistry and regulatory expertise.

Operating multiple state-of-the-art manufacturing and research facilities worldwide, the company complies with major international regulatory authorities including the US FDA, EMA, Swissmedic, and PMDA. Continuous investment in innovation, sustainability, digital manufacturing, and scientific research enables Dishman Carbogen Amcis to deliver reliable pharmaceutical manufacturing solutions to global healthcare organizations. Its reputation for quality, technical excellence, and customer collaboration makes it one of the world’s leading API manufacturing partners.